FMCT-ct1.

We are in the preliminary planning to fund a two-armed, phase 2 clinical trial testing the adjunctive efficacy of the ketogenic diet (arm-1), and a metabolic “press-pulse”, combination therapy (arm-2) on Glioblastoma multiforme. These two intervention arms will be compared to the median overall survival of historical controls in order to determine efficacy. This will be the largest and most comprehensive study of the efficacy of adjunctive metabolic therapies to date.

onenine

Clinical Trials

07/12/2025

Other Projects of Interest

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

This is a Phase 2, randomized two-armed, multi-site study of 170 patients with newly diagnosed glioblastoma multiforme. Patients will be

Preclinical Studies

FMCT-pc3.

We are funding research to test the preclinical efficacy of a special formulation of mebendazole designed to make the active

Preclinical Studies

FMCT-pc2.

We are funding a study that aims to optimize an in vitro experimental assay that is capable of testing individual